MIM
Monashee Investment Management Portfolio holdings
AUM
$190M
This Quarter Return
+2.09%
1 Year Return
+42.84%
3 Year Return
+185.9%
5 Year Return
+237.5%
10 Year Return
+2,730.86%
AUM
$405M
AUM Growth
+$405M
(-25%)
Cap. Flow
-$134M
Cap. Flow
% of AUM
-33.22%
Top 10 Holdings %
Top 10 Hldgs %
79.23%
Holding
289
New
27
Increased
4
Reduced
8
Closed
245
Top Buys
| 1 |
Vanguard Total Stock Market ETF
VTI
|
$56.8M |
| 2 |
Hyperfine
HYPR
|
$15.7M |
| 3 |
Agree Realty
ADC
|
$8.92M |
| 4 |
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
|
$8.19M |
| 5 |
DocGo
DCGO
|
$7.01M |
Top Sells
| 1 |
Maravai LifeSciences
MRVI
|
$9.08M |
| 2 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
$7.64M |
| 3 |
ML
MoneyLion Inc.
ML
|
$6.77M |
| 4 |
Foghorn Therapeutics
FHTX
|
$6.65M |
| 5 |
RBC Bearings
RBC
|
$5.31M |
Sector Composition
| 1 | Healthcare | 24.5% |
| 2 | Financials | 4.73% |
| 3 | Real Estate | 2.66% |
| 4 | Materials | 1.45% |
| 5 | Consumer Staples | 1.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vanguard Total Stock Market ETF
VTI
$526B
| $246M | 60.73% | 1,017,700 +235,400 | +30% | +$56.8M |
|
|
2
Hyperfine
HYPR
$97.4M
| $15.7M | 3.89% | +2,171,395 | New | +$15.7M |
|
|
SLGC
3
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $9.66M | 2.39% | 830,000 -656,135 | -44% | -$7.64M |
|
|
4
Agree Realty
ADC
$8.05B
| $8.92M | 2.2% | +125,000 | New | +$8.92M |
|
|
PRDS
5
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $8.19M | 2.02% | +500,000 | New | +$8.19M |
|
6
Caribou Biosciences
CRBU
$174M
| $7.61M | 1.88% | 504,377 +55,000 | +12% | +$830K |
|
|
7
DocGo
DCGO
$153M
| $7.01M | 1.73% | +750,000 | New | +$7.01M |
|
8
Compass Therapeutics
CMPX
$483M
| $6.34M | 1.57% | +2,000,000 | New | +$6.34M |
|
|
VIEW
9
DELISTED
View, Inc. Class A Common Stock
VIEW
| $5.87M | 1.45% | 1,500,000 | – | – |
|
|
10
Foghorn Therapeutics
FHTX
$286M
| $5.49M | 1.36% | 240,000 -290,581 | -55% | -$6.65M |
|
11
Natera
NTRA
$23.1B
| $5.14M | 1.27% | 55,000 +20,000 | +57% | +$1.87M |
|
|
OMGA
12
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $5M | 1.24% | 441,176 | – | – |
|
13
Fulcrum Therapeutics
FULC
$351M
| $4.83M | 1.19% | +273,045 | New | +$4.83M |
|
14
SoFi Technologies
SOFI
$30.6B
| $4.74M | 1.17% | +300,000 | New | +$4.74M |
|
15
Wheels Up
UP
$2.05B
| $4.28M | 1.06% | 922,461 -650,000 | -41% | -$3.02M |
|
|
LUCK
16
Lucky Strike Entertainment Corporation
LUCK
$1.5B
| $4.06M | 1% | +450,000 | New | +$4.06M |
|
17
KalVista Pharmaceuticals
KALV
$678M
| $3.97M | 0.98% | 300,000 +175,000 | +140% | +$2.32M |
|
18
PLAYSTUDIOS Inc
MYPS
$121M
| $3.95M | 0.98% | 1,000,000 | – | – |
|
|
PCPC
19
DELISTED
Periphas Capital Partnering Corporation
PCPC
| $3.56M | 0.88% | 146,222 | – | – |
|
20
Xilio Therapeutics
XLO
$36.3M
| $3.43M | 0.85% | +214,253 | New | +$3.43M |
|
|
FOCS
21
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $3.29M | 0.81% | +55,000 | New | +$3.29M |
|
22
Blue Owl Capital
OWL
$12.1B
| $3.28M | 0.81% | +220,000 | New | +$3.28M |
|
|
CLYM
23
Climb Bio, Inc. Common Stock
CLYM
$151M
| $3.14M | 0.78% | 300,000 -5,233 | -2% | -$54.7K |
|
24
Hain Celestial
HAIN
$162M
| $3.09M | 0.76% | +72,507 | New | +$3.09M |
|
25
Humacyte
HUMA
$245M
| $2.9M | 0.72% | 399,910 -350,090 | -47% | -$2.54M |
|